Literature DB >> 28213008

The prognostic impact of tumor volume on stage I non-small cell lung cancer.

Xiao-Dong Su1, Hao-Jun Xie2, Qian-Wen Liu2, Yun-Xian Mo3, Hao Long2, Tie-Hua Rong2.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the prognostic impact of tumor volume (TV) on patients with stage I non-small cell lung cancer (NSCLC) after complete resection.
MATERIALS AND METHODS: We retrospectively reviewed the clinicopathological characteristics of 274 patients with stage I NSCLC who had received preoperative chest computed tomography (CT) scans and complete resection. TV was semi-automatically measured from chest CT scans by using an imaging software program. The optimal cutoff values of TV were determined by X-tile software. Disease-free survival (DFS) and overall survival (OS) were compared using Kaplan-Meier analysis. Univariate and multivariate analyses were performed to identify risk factors for DFS and OS.
RESULTS: By using 3.046cm3 and 8.078cm3 as two optimal cutoff values of TV, the patients were separated into three groups. The 5-year DFS and OS for patients with TV≤3.046cm3, 3.046-8.078cm3, and>8.078cm3 were 88.0%, 73.6%, and 62.1%, respectively (P<0.001), and 91.4%, 84.5%, and 73.3%, respectively (p<0.001). Multivariate analysis showed that age and TV were independent factors associated with DFS. Sex, age, histology, visceral pleural invasion, and TV were independent factors associated with OS. Stage Ia patients might be separated into three groups on the basis of TV with significantly different DFS and OS. Patients with tumor diameter≤2cm and 2-3cm were also stratified into two groups with significantly different DFS and OS on the basis of TV, respectively.
CONCLUSION: TV is an independent risk factor for DFS and OS for stage I NSCLC after complete resection. TV might provide additional prognostic information over tumor diameter in patients with stage I NSCLC. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Non-small cell lung cancer; Prognosis; Stage I; Surgery; Tumor volume

Mesh:

Year:  2016        PMID: 28213008     DOI: 10.1016/j.lungcan.2016.12.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  7 in total

1.  Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.

Authors:  Olarn Roengvoraphoj; Cherylina Wijaya; Chukwuka Eze; Minglun Li; Maurice Dantes; Julian Taugner; Amanda Tufman; Rudolf Maria Huber; Claus Belka; Farkhad Manapov
Journal:  Strahlenther Onkol       Date:  2017-11-07       Impact factor: 3.621

2.  Tumor volume is more reliable to predict nodal metastasis in non-small cell lung cancer of 3.0 cm or less in the greatest tumor diameter.

Authors:  Bei Jia; Biao Chen; Hao Long; Tiehua Rong; Xiaodong Su
Journal:  World J Surg Oncol       Date:  2020-07-15       Impact factor: 2.754

3.  Prognostic influence of 3-dimensional tumor volume on breast cancer compared to conventional 1-dimensional tumor size.

Authors:  Ki-Tae Hwang; Wonshik Han; Sang Mok Lee; Jaewoo Choi; Jongjin Kim; Jiyoung Rhu; Young A Kim; Dong-Young Noh
Journal:  Ann Surg Treat Res       Date:  2018-09-28       Impact factor: 1.859

4.  The Study of Tumor Volume as a Prognostic Factor in T Staging System for Non-Small Cell Lung Cancer: An Exploratory Study.

Authors:  Bei Jia; Xu Zhang; Yunxian Mo; Biao Chen; Hao Long; Tiehua Rong; Xiaodong Su
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes.

Authors:  David Lang; Linda Ritzberger; Vanessa Rambousek; Andreas Horner; Romana Wass; Kaveh Akbari; Bernhard Kaiser; Jürgen Kronbichler; Bernd Lamprecht; Michael Gabriel
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

6.  Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma.

Authors:  Hyun Woo Jeon; Young-Du Kim; Sung Bo Sim; Mi Hyoung Moon
Journal:  Thorac Cancer       Date:  2022-04-13       Impact factor: 3.223

7.  Prognostic factors for surgically resected non-small cell lung cancer with cavity formation.

Authors:  Shunsuke Shigefuku; Yujin Kudo; Daisuke Yunaiyama; Jun Matsubayashi; Jinho Park; Toshitaka Nagao; Yoshihisa Shimada; Hisashi Saji; Masaru Hagiwara; Tetsuya Okano; Masatoshi Kakihana; Naohiro Kajiwara; Tatsuo Ohira; Norihiko Ikeda
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.